Zai Lab
ZLAB
70 hedge funds and large institutions have $626M invested in Zai Lab in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 6 closing their positions.
167% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 6
61% more call options, than puts
Call options by funds: $469K | Put options by funds: $292K
50% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 18
27% more capital invested
Capital invested by funds: $493M → $626M (+$133M)
15% more funds holding
Funds holding: 61 → 70 (+9)
0.03% more ownership
Funds ownership: 36.47% → 36.5% (+0.03%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$15.6M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$12.4M |
| 3 |
BlackRock
New York
|
+$7.23M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$5.06M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.2M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$13.4M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12M |
| 4 |
O
OrbiMed
New York
|
-$9.64M |
| 5 |
Millennium Management
New York
|
-$6.15M |
ZLAB Hedge Fund Activity: Q1 2019 in Review
70 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Zai Lab (ZLAB) for Q1 2019, worth a combined $626M — up 27% from $493M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ZLAB positions and 6 closed out — a net gain of 10 holders — while 27 added to existing stakes and 18 trimmed.
The largest buyer was Credit Suisse, adding an estimated $15.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $14.2M.
- 70 institutional investors held Zai Lab (ZLAB) as of Q1 2019, up from 61 in Q4 2018.
- Funds reported $626M of Zai Lab stock for Q1 2019, up 27% quarter-over-quarter.
- 16 funds opened new Zai Lab positions in Q1 2019 and 6 closed out, a net change of +10 holders.
- The largest Zai Lab buyer in Q1 2019 was Credit Suisse, an estimated $15.6M added.
- The largest Zai Lab seller in Q1 2019 was T. Rowe Price Associates, an estimated $14.2M sold.
Based on aggregated 13F filings for Q1 2019.